Fonseca Biosciences Drug Patent Portfolio

Fonseca Biosciences owns 1 orange book drug protected by 6 US patents Given below is the list of Fonseca Biosciences's drug patents along with their expiration dates.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US9504691 Finafloxacin suspension compositions 21 Nov, 2033
Active
US8536167 Methods for treating ophthalmic, otic, or nasal infections 08 Aug, 2031
Active
US9119859 Methods for treating otic infections 02 Jul, 2030
Active
US9993483 Compositions and methods for treating ophthalmic, octic, or nasal infections 02 Jul, 2030
Active
US6133260 Use of 7-(2-oxa-5,8-diazabicyclo[4.3.0]non-8-yl)-quinolone carboxylic acid and naphthyridon carboxylic acid derivatives for the treatment of Helicobacter pylori infections and associated gastroduodenal diseases 12 Apr, 2017 Expired
US6432948 Use of 7-(2-oxa-5,8-diazabicylco[4.3.0]non-8-yl)-quinolone carboxylic acid and naphthyridon carboxylic acid derivatives for the treatment of heliobacter pylori infections and associated gastroduodenal diseases 12 Apr, 2017 Expired


Given below is the list of recent legal activities going on the following drug patents of Fonseca Biosciences.

Activity Date Patent Number
Patent litigations
Payment of Maintenance Fee, 8th Yr, Small Entity 06 May, 2024 US9504691
Payment of Maintenance Fee, 8th Yr, Small Entity 21 Feb, 2023 US9119859
Change in Power of Attorney (May Include Associate POA) 23 Nov, 2022 US9993483
Change in Power of Attorney (May Include Associate POA) 14 Nov, 2022 US9119859
Change in Power of Attorney (May Include Associate POA) 10 Nov, 2022 US9504691
Change in Power of Attorney (May Include Associate POA) 10 Nov, 2022 US8536167
Change in Power of Attorney (May Include Associate POA) 26 Oct, 2022 US9119859
Change in Power of Attorney (May Include Associate POA) 26 Oct, 2022 US9993483
Change in Power of Attorney (May Include Associate POA) 26 Oct, 2022 US8536167
Change in Power of Attorney (May Include Associate POA) 26 Oct, 2022 US9504691
Payment of Maintenance Fee, 4th Yr, Small Entity 13 Dec, 2021 US9993483
Payment of Maintenance Fee, 8th Yr, Small Entity 30 Sep, 2020 US8536167
Applicant Has Filed a Verified Statement of Small Entity Status in Compliance with 37 CFR 1.27 06 Jul, 2020 US9119859
Applicant Has Filed a Verified Statement of Small Entity Status in Compliance with 37 CFR 1.27 06 Jul, 2020 US9993483
Applicant Has Filed a Verified Statement of Small Entity Status in Compliance with 37 CFR 1.27 06 Jul, 2020 US8536167


Fonseca Biosciences's Family Patents

Fonseca Biosciences drugs have patent protection in a total of 18 countries. It's US patent count contributes only to 21.4% of its total global patent coverage. 5 countries have all of their patents expired or invalidated which has opened up potential generic launch opportunities in these countries. Click below to unlock the full patent family tree.

Family Patents



Fonseca Biosciences Drug List

Given below is the complete list of Fonseca Biosciences's drugs and the patents protecting them.


1. Xtoro

Xtoro is protected by 6 patents, out of which 2 have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US9504691 Finafloxacin suspension compositions 21 Nov, 2033
(8 years from now)
Active
US8536167 Methods for treating ophthalmic, otic, or nasal infections 08 Aug, 2031
(6 years from now)
Active
US9119859 Methods for treating otic infections 02 Jul, 2030
(5 years from now)
Active
US9993483 Compositions and methods for treating ophthalmic, octic, or nasal infections 02 Jul, 2030
(5 years from now)
Active
US6133260 Use of 7-(2-oxa-5,8-diazabicyclo[4.3.0]non-8-yl)-quinolone carboxylic acid and naphthyridon carboxylic acid derivatives for the treatment of Helicobacter pylori infections and associated gastroduodenal diseases 12 Apr, 2017
(7 years ago)
Expired
US6432948 Use of 7-(2-oxa-5,8-diazabicylco[4.3.0]non-8-yl)-quinolone carboxylic acid and naphthyridon carboxylic acid derivatives for the treatment of heliobacter pylori infections and associated gastroduodenal diseases 12 Apr, 2017
(7 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Xtoro's drug page


Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List